Diabetes

WHO push to tackle rampant rise of diabetes

The World Health Organization on Wednesday turned the spotlight on the insulin market—and its domination by three Big Pharma giants—in a fresh bid to tackle the rapid rise of diabetes.

Medications

EU forces S.Africa firm to slash cancer drug prices

The European Commission said Wednesday it had forced South African drugs giant Aspen to slash prices on six cancer drugs after finding it abused its market dominance to hike charges.

Medications

Industry executives: Profits drive rising prices for MS drugs

U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...

Diabetes

Insulin price more than doubled in the US

(HealthDay)—Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.

page 2 from 3